No two vintage chairs match and an egalitarian menu caters to every taste and appetite: homemade soup, fries, fashionable poke bowls, guacamole dips and the gambit ... own on a bluebird day ...

Channing Tatum‘s axed Gambit movie was a “screwball romantic comedy,” Lizzy Caplan recently revealed to Business Insider. Variety reported in November 2017 that Caplan had boarded Tatum’s ...

More than five years after the Gambit solo movie was scrapped, attached actor Lizzy Caplan has revealed story details for the Channing Tatum-led X-Men spin-off. First announced in 2014 ...

Lizzy Caplan is sharing details on what the scrapped Gambit movie would’ve been like. In 2017, Deadline reported that Caplan was in talks to co-star alongside Channing Tatum in a standalone film ...

bluebird stockholders to receive $3.00 per share in cash and a contingent value right of $6.84 per share in cash payable upon achievement of a net sales milestone, contingent upon offer conditions ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today announced that it has entered into a definitive agreement to be acquired by funds managed by global ...

Tatum finally realized his dream of playing Remy LeBeau, better known as Gambit, in 2024’s blockbuster Deadpool & Wolverine. After nearly a decade of trying to bring the Cajun mutant to the big ...

Flying high as one of the world’s premier developers of gene therapies in early 2018, bluebird bio’s share price hit a dizzying $2,300 apiece. But seven years later—after failing to build a ...

Bluebird bio to be acquired by Carlyle Group & SK Capital, offering up to $9.84/share based on product performance. Former Mirati CEO David Meek set to lead bluebird post-acquisition, with deal ...

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. Bluebird on ...

Bluebird bio will be acquired by investment firms Carlyle and SK Capital Partners, marking the end to its turbulent time as a publicly traded company. The agreement comes after years of financial ...

Shares of bluebird bio (NASDAQ:BLUE) continued their downward descent Monday in the wake of news that the company has agreed to be taken private by Carlyle Group (NASDAQ:CG) and SK Capital ...